Clinical Trials · NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 125
- Start date
- Nov 2024
- Locations
- 50 sites, 8 countries
- Primary endpoint
- Number of Participants Allocated to Each ISA